0,867  0,004  Caspase 9 stimulant
0,799  0,004  Tubulin antagonist
0,764  0,013  Antineoplastic (breast cancer)
0,760  0,012  Antineoplastic (lung cancer)
0,738  0,011  Antineoplastic (colorectal cancer)
0,731  0,011  Antineoplastic (colon cancer)
0,741  0,024  Apoptosis agonist
0,687  0,003  Alpha tubulin antagonist
0,689  0,007  Cardiovascular analeptic
0,685  0,011  Prostate cancer treatment
0,668  0,008  NOS2 expression inhibitor
0,679  0,023  Transcription factor NF kappa B inhibitor
0,653  0,009  UGT1A9 substrate
0,651  0,013  Aldehyde oxidase inhibitor
0,640  0,005  Antimitotic
0,643  0,010  Antineoplastic (cervical cancer)
0,633  0,003  Beta tubulin antagonist
0,634  0,014  Antihypercholesterolemic
0,616  0,009  Antineoplastic (non-small cell lung cancer)
0,611  0,023  TNF expression inhibitor
0,586  0,018  Vasodilator, peripheral
0,585  0,017  Antineoplastic (ovarian cancer)
0,571  0,013  Antioxidant
0,571  0,016  Antineoplastic (melanoma)
0,563  0,013  Caspase 3 stimulant
0,578  0,027  Antileukemic
0,552  0,005  UGT2B4 substrate
0,541  0,014  Antineoplastic (multiple myeloma)
0,542  0,015  Ulceration
0,537  0,013  Free radical scavenger
0,540  0,017  Antineoplastic (pancreatic cancer)
0,539  0,021  5 Hydroxytryptamine release stimulant
0,542  0,034  CYP3A4 substrate
0,516  0,010  RNA-directed DNA polymerase inhibitor
0,499  0,007  Antineoplastic (squamous cell carcinoma)
0,492  0,004  Pneumotoxic
0,506  0,020  AR expression inhibitor
0,497  0,013  UGT1A6 substrate
0,488  0,005  Calcium channel activator
0,500  0,019  Chemopreventive
0,501  0,020  Cytostatic
0,499  0,019  Antineoplastic (glioma)
0,482  0,009  P-glycoprotein inhibitor
0,485  0,016  Hypoxia-inducible factor 1 alpha inhibitor
0,515  0,048  Antineoplastic (solid tumors)
0,469  0,009  Hepatoprotectant
0,476  0,017  Antineoplastic (glioblastoma multiforme)
0,481  0,025  Hepatic disorders treatment
0,465  0,012  Antimutagenic
0,469  0,026  Cardioprotectant
0,480  0,039  Antipruritic, allergic
0,447  0,011  UGT1A4 substrate
0,444  0,010  UGT1A3 substrate
0,457  0,027  CTGF expression inhibitor
0,452  0,026  Lipoxygenase inhibitor
0,444  0,020  Amyloid beta aggregation inhibitor
0,443  0,021  Nitric oxide antagonist
0,426  0,008  Lipid peroxidase inhibitor
0,429  0,011  Antineoplastic (carcinoma)
0,439  0,021  Antipyretic
0,439  0,024  Proliferative diseases treatment
0,499  0,088  Antiinflammatory
0,417  0,011  Antiseptic
0,434  0,029  Chemoprotective
0,435  0,034  Spasmolytic
0,407  0,008  UGT2B15 substrate
0,427  0,028  Vasodilator, coronary
0,429  0,032  12-Lipoxygenase inhibitor
0,409  0,015  Antineoplastic (sarcoma)
0,401  0,008  Tyrosine 3 hydroxylase inhibitor
0,407  0,020  Antineoplastic (osteosarcoma)
0,407  0,026  Tumour necrosis factor alpha release inhibitor
0,413  0,036  Antineoplastic (brain cancer)
0,392  0,018  Cyclic AMP phosphodiesterase inhibitor
0,408  0,035  Cytotoxic
0,396  0,024  Vasodilator
0,400  0,028  DNA damaging
0,390  0,020  Sodium/bile acid cotransporter inhibitor
0,372  0,003  UGT2B10 substrate
0,394  0,025  Antineoplastic (renal cancer)
0,420  0,053  CYP2C19 inhibitor
0,386  0,018  UGT1A1 substrate
0,403  0,039  ICAM1 expression inhibitor
0,374  0,011  Amylase inhibitor
0,425  0,064  15-Lipoxygenase inhibitor
0,375  0,014  UGT2B7 substrate
0,418  0,057  Immunosuppressant
0,382  0,022  UDP-glucuronosyltransferase substrate
0,402  0,044  Teratogen
0,416  0,058  CYP2C9 substrate
0,399  0,041  CYP2C19 substrate
0,369  0,012  VCAM1 expression inhibitor
0,374  0,019  5 Hydroxytryptamine uptake stimulant
0,362  0,011  Antineoplastic (gastric cancer)
0,357  0,008  Neurotrophic factor enhancer
0,359  0,017  Antihypotensive
0,346  0,009  Acetylcholinesterase inhibitor
0,379  0,043  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,380  0,048  Respiratory analeptic
0,369  0,038  Sensitization
0,361  0,034  Cardiodepressant
0,354  0,028  Antihypertriglyceridemic
0,377  0,052  FMO1 substrate
0,380  0,055  Antithrombotic
0,348  0,025  Antineoplastic (bladder cancer)
0,427  0,104  Alpha-glucosidase inhibitor
0,334  0,014  Genotoxic
0,346  0,026  Abortion inducer
0,344  0,035  Transcription factor STAT3 inhibitor
0,316  0,010  NADPH oxidase inhibitor
0,337  0,032  Antineoplastic (lymphocytic leukemia)
0,343  0,041  Antiamyloidogenic
0,305  0,005  Dopamine D1 antagonist
0,327  0,028  Sedative
0,358  0,061  Cholesterol antagonist
0,341  0,045  CYP1A2 inhibitor
0,310  0,019  Interferon gamma antagonist
0,315  0,027  Antiviral (Influenza)
0,308  0,021  Antipruritic, non-allergic
0,295  0,010  Cystathionine beta-synthase inhibitor
0,337  0,052  Embryotoxic
0,303  0,018  Cholinergic
0,373  0,089  Histamine release inhibitor
0,323  0,041  Vascular (periferal) disease treatment
0,371  0,090  Antibacterial
0,338  0,062  Apoptosis antagonist
0,324  0,053  Antineoplastic (small cell lung cancer)
0,293  0,023  Melanin inhibitor
0,327  0,060  Analeptic
0,281  0,015  Antineoplastic (bone cancer)
0,308  0,042  GST M1-1 substrate
0,278  0,014  UGT2B9 substrate
0,311  0,047  Antineoplastic (liver cancer)
0,325  0,063  NOS3 expression inhibitor
0,309  0,048  Antidiabetic symptomatic
0,269  0,011  Expectorant
0,282  0,025  Contraceptive
0,264  0,017  Heat shock protein 90 antagonist
0,253  0,007  Dopamine agonist
0,253  0,008  Microtubule formation inhibitor
0,260  0,017  LDLR expression enhancer
0,297  0,055  Antiprotozoal (Leishmania)
0,264  0,022  Topoisomerase II inhibitor
0,353  0,112  5 Hydroxytryptamine release inhibitor
0,304  0,066  CYP1A2 substrate
0,244  0,007  Arachidonic acid antagonist
0,239  0,010  Choleretic
0,311  0,082  Bone diseases treatment
0,283  0,055  Antineoplastic (lymphoma)
0,288  0,063  Transcription factor STAT inhibitor
0,283  0,057  Superoxide dismutase inhibitor
0,251  0,026  Protein kinase stimulant
0,250  0,025  Antiviral (Influenza A)
0,236  0,012  Toll-Like receptor 2 antagonist
0,260  0,038  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,291  0,070  Antiosteoporotic
0,245  0,024  Succinate dehydrogenase inhibitor
0,243  0,027  Skin whitener
0,217  0,003  UGT2B11 substrate
0,293  0,085  Antineoplastic (endocrine cancer)
0,216  0,009  HIV-1 integrase (3'-Processing) inhibitor
0,216  0,008  HIV-1 integrase (Strand Transfer) inhibitor
0,229  0,025  M18 aspartyl aminopeptidase inhibitor
0,206  0,006  CDC25A inhibitor
0,250  0,050  Anesthetic general
0,285  0,088  Antifungal
0,209  0,014  UGT2B1 substrate
0,245  0,051  Platelet adhesion inhibitor
0,199  0,005  Dopamine D2 agonist
0,224  0,030  Antidote
0,209  0,017  SULT1A1 substrate
0,225  0,034  Skeletal muscle relaxant
0,247  0,056  Antineoplastic enhancer
0,318  0,128  Antiparkinsonian
0,220  0,032  VEGF expression inhibitor
0,231  0,045  Muscle relaxant
0,257  0,072  Hypoglycemic
0,232  0,047  Nitric-oxide synthase stimulant
0,202  0,018  Alpha 2c adrenoreceptor antagonist
0,205  0,020  Antihemorrhagic
0,211  0,028  Antifungal enhancer
0,206  0,023  5-Lipoxygenase inhibitor
0,204  0,023  Alpha 2b adrenoreceptor antagonist
0,244  0,062  Antiulcerative
0,229  0,052  Non-steroidal antiinflammatory agent
0,226  0,050  CYP2B6 inhibitor
0,193  0,019  Antihelmintic (Trematoda)
0,203  0,029  SULT1A3 substrate
0,186  0,013  Antiviral (Influenza B)
0,190  0,019  Alpha 2 adrenoreceptor antagonist
0,198  0,027  Cholesterol synthesis inhibitor
0,208  0,037  Toxic, respiratory center
0,253  0,083  Radiosensitizer
0,192  0,022  Cyclooxygenase 3 inhibitor
0,203  0,034  Antidiarrheal
0,227  0,061  Carcinogenic
0,186  0,021  Adenylate cyclase stimulant
0,208  0,044  Heat shock protein 90 alpha antagonist
0,181  0,019  Sulfotransferase substrate
0,165  0,004  Heat shock protein 90 beta antagonist
0,170  0,009  Antifungal (Pneumocystis)
0,165  0,004  Topoisomerase II beta inhibitor
0,242  0,083  5 Hydroxytryptamine 1E antagonist
0,173  0,014  Prolactin inhibitor
0,172  0,019  Antineoplastic (uterine cancer)
0,225  0,072  Antiviral (HIV)
0,275  0,125  GST A substrate
0,171  0,021  Photosensitizer
0,214  0,063  Mutagenic
0,169  0,020  Topoisomerase II alpha inhibitor
0,218  0,069  Antialcoholic
0,169  0,022  Antineoplastic alkaloid
0,152  0,006  Dopamine D5 antagonist
0,204  0,059  Dual specificity phosphatase 3 inhibitor
0,168  0,023  Contraceptive female
0,158  0,014  Anabolic
0,170  0,027  Antineoplastic antibiotic
0,281  0,137  Antiprotozoal
0,163  0,020  Multidrug resistance-associated protein 1 inhibitor
0,155  0,012  Aromatase inhibitor
0,156  0,013  Acetylcholine release stimulant
0,227  0,086  DNA synthesis inhibitor
0,161  0,020  Androgen antagonist
0,161  0,020  Alpha 2a adrenoreceptor antagonist
0,213  0,072  Platelet aggregation inhibitor
0,174  0,034  Antieczematic
0,159  0,020  Estrogen antagonist
0,164  0,025  Mucolytic
0,172  0,034  Antitussive
0,154  0,017  Antiprotozoal (Toxoplasma)
0,164  0,027  Vanilloid 1 agonist
0,169  0,035  Topoisomerase I inhibitor
0,153  0,020  DOPA decarboxylase inhibitor
0,145  0,016  Contraceptive male
0,140  0,012  Estrogen agonist
0,177  0,050  Carcinogenic, group 1
0,159  0,033  Coagulant
0,178  0,054  Hair growth stimulant
0,184  0,060  Antirickettsial
0,142  0,018  SULT1E1 substrate
0,211  0,089  Angiogenesis stimulant
0,180  0,058  ATPase inhibitor
0,154  0,034  Ca2+-transporting ATPase inhibitor
0,244  0,127  Angiogenesis inhibitor
0,184  0,067  Sigma receptor agonist
0,252  0,138  Antiprotozoal (Plasmodium)
0,156  0,044  Alkylator
0,165  0,053  Antiprotozoal (Coccidial)
0,165  0,054  Anesthetic
0,143  0,033  AMP-activated protein kinase stimulant
0,126  0,017  Estrogen receptor alpha antagonist
0,124  0,016  Glycine receptor antagonist
0,122  0,014  Granulocyte macrophage colony stimulating factor agonist
0,201  0,093  Hypolipemic
0,176  0,070  Dual specificity phosphatase inhibitor
0,120  0,015  HIV-1 integrase inhibitor
0,195  0,090  Antiparasitic
0,129  0,024  Estrogen receptor beta antagonist
0,162  0,057  CF transmembrane conductance regulator agonist
0,177  0,073  Lipocortins synthesis antagonist
0,141  0,038  GST P1-1 substrate
0,141  0,037  Constipation treatment
0,140  0,038  Butyrylcholinesterase inhibitor
0,144  0,043  Glutathione S-transferase substrate
0,159  0,057  Mannose-6-phosphate isomerase inhibitor
0,105  0,005  Transcription factor RelA inhibitor
0,107  0,008  Estrogen receptor alpha agonist
0,161  0,062  NOS3 expression enhancer
0,104  0,005  Postcoital contraceptive
0,105  0,007  SULT2A1 substrate
0,119  0,022  Keratolytic
0,131  0,034  Electron transport complex I inhibitor
0,163  0,067  Protein-tyrosine phosphatase inhibitor
0,120  0,025  Restless leg syndrome treatment
0,176  0,082  DNA methyltransferase I inhibitor
0,184  0,090  DNA methylase inhibitor
0,163  0,070  Uterine stimulant
0,183  0,091  Insulin sensitizer
0,146  0,055  Heat shock protein 70 antagonist
0,120  0,029  Carbonic anhydrase VI inhibitor
0,181  0,092  Psychostimulant
0,147  0,058  Pregnane X receptor agonist
0,162  0,072  Peroxidase inhibitor
0,168  0,079  Tumour necrosis factor antagonist
0,116  0,027  Inducible nitric-oxide synthase inhibitor
0,113  0,025  ATPase (Vacuolar H+) inhibitor
0,133  0,045  Endometrios treatment
0,173  0,086  Antihelmintic
0,104  0,017  Aldose reductase inhibitor
0,118  0,030  Carbonic anhydrase XIII inhibitor
0,138  0,052  Monophenol monooxygenase inhibitor
0,205  0,119  Radioprotector
0,204  0,120  Lipoprotein disorders treatment
0,157  0,073  Antiviral (Herpes)
0,087  0,005  Dopamine D5 agonist
0,156  0,074  Eye irritation, high
0,274  0,192  Alzheimer's disease treatment
0,097  0,016  Androgen agonist
0,135  0,055  Gastritis treatment
0,084  0,004  Dopamine D1 agonist
0,113  0,034  Dopamine antagonist
0,102  0,023  Narcotic antagonist
0,137  0,059  Antibacterial (Helicobacter pylori)
0,090  0,012  Estradiol 17 beta-dehydrogenase inhibitor
0,120  0,043  Dementia treatment
0,156  0,080  Interleukin 6 antagonist
0,133  0,057  Antiviral (Hepatitis B)
0,115  0,043  Vascular dementia treatment
0,212  0,140  Insulysin inhibitor
0,114  0,044  HIV-1 integrase (Overall Integration) inhibitor
0,121  0,052  Gout treatment
0,101  0,032  Dopamine D2 antagonist
0,101  0,032  Vanilloid agonist
0,100  0,032  Histidine decarboxylase inhibitor
0,112  0,045  Breast cancer-resistant protein inhibitor
0,116  0,049  Xanthine oxidase inhibitor
0,119  0,053  Protein kinase C gamma inhibitor
0,108  0,042  Protein kinase C zeta inhibitor
0,204  0,139  CYP2D6 substrate
0,114  0,049  Alpha adrenoreceptor antagonist
0,097  0,034  Na+ K+ transporting ATPase inhibitor
0,094  0,034  Estrogen-related receptor beta agonist
0,089  0,029  Glycine receptor agonist
0,136  0,077  Antiparkinsonian, tremor relieving
0,110  0,052  Carbonic anhydrase III inhibitor
0,073  0,015  Ryanodine receptor antagonist
0,103  0,045  Paget's disease treatment
0,130  0,072  Cocaine dependence treatment
0,224  0,167  Stroke treatment
0,114  0,059  Chelator
0,126  0,072  Antihyperlipoproteinemic
0,148  0,094  Liver fibrosis treatment
0,085  0,032  Antitreponemal
0,077  0,023  Postmenopausal disorders treatment
0,118  0,065  Protein-tyrosine phosphatase 1B inhibitor
0,096  0,043  Antiviral (Trachoma)
0,109  0,057  Toll-Like receptor 4 antagonist
0,180  0,129  Myocardial infarction treatment
0,204  0,154  Prostaglandin dehydrogenase inhibitor
0,064  0,014  Factor III inhibitor
0,089  0,040  Antibiotic
0,097  0,048  Ornithine decarboxylase inhibitor
0,136  0,087  Hemostatic
0,151  0,104  Phospholipase C inhibitor
0,069  0,022  Lipocortins synthesis agonist
0,123  0,077  Cyclooxygenase 1 inhibitor
0,063  0,017  Estrogen receptor beta agonist
0,066  0,020  Pregnane X receptor antagonist
0,089  0,044  NAD(P)H dehydrogenase (quinone) inhibitor
0,204  0,159  FMO3 substrate
0,125  0,081  Bone formation stimulant
0,124  0,080  Interleukin 4 antagonist
0,068  0,023  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,071  0,027  Calcium channel P-type blocker
0,075  0,032  5 Hydroxytryptamine 2A agonist
0,164  0,121  Antiparkinsonian, rigidity relieving
0,155  0,111  Pyruvate kinase inhibitor
0,101  0,058  Creatine kinase inhibitor
0,092  0,051  Interleukin 5 antagonist
0,248  0,207  Calcium channel L-type activator
0,074  0,033  CDC25B inhibitor
0,050  0,008  Tubulin agonist
0,083  0,042  SULT1A2 substrate
0,122  0,082  Toll-Like receptor antagonist
0,087  0,048  Opioid kappa receptor antagonist
0,120  0,081  Papain-like protease (SARS coronavirus) inhibitor
0,152  0,114  Phobic disorders treatment
0,061  0,023  Glucose-6-phosphate translocase inhibitor
0,054  0,017  Progesterone antagonist
0,095  0,059  Antiadrenergic
0,096  0,061  Protein kinase C mu inhibitor
0,108  0,074  TRPA1 agonist
0,068  0,033  Transcription factor AP-1 inhibitor
0,075  0,041  Elastase 1 inhibitor
0,068  0,034  Antimycoplasmal
0,125  0,091  Acaricide
0,138  0,105  Prostate disorders treatment
0,044  0,011  Catechol O-methyltransferase inhibitor
0,091  0,059  Adrenaline antagonist
0,063  0,032  Bcl-xL inhibitor
0,112  0,080  Growth stimulant
0,058  0,026  Vanilloid 2 antagonist
0,070  0,039  Beta adrenoreceptor antagonist
0,100  0,069  Beta glucuronidase inhibitor
0,044  0,013  Melatonin 2 agonist
0,083  0,054  Thioredoxin reductase inhibitor
0,094  0,064  Bile acid receptor antagonist
0,055  0,026  Squalene epoxidase inhibitor
0,065  0,036  Alpha 2 adrenoreceptor agonist
0,056  0,029  Prolyl endopeptidase inhibitor
0,055  0,028  Anesthetic inhalation
0,120  0,094  Neurotrophic factor
0,058  0,032  Protein 50S ribosomal subunit inhibitor
0,096  0,071  GABA C receptor agonist
0,145  0,121  Antiarrhythmic
0,105  0,082  Carcinogenic, group 3
0,158  0,136  Platelet antagonist
0,183  0,161  Flavin-containing monooxygenase substrate
0,062  0,041  Antidote, heavy metal
0,027  0,006  Progesterone receptor B antagonist
0,135  0,114  Antipruritic
0,113  0,093  Antiviral (Papilloma)
0,067  0,048  Andropause treatment
0,170  0,151  Antiprotozoal (Trypanosoma)
0,040  0,021  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,098  0,080  GST T1-1 substrate
0,085  0,067  Actinic keratosis treatment
0,062  0,043  Dopamine D3 antagonist
0,077  0,060  Phosphodiesterase 3A inhibitor
0,066  0,049  Glutamate (mGluR6) antagonist
0,108  0,091  Alcohol dehydrogenase substrate
0,040  0,024  5-Alpha-reductase inhibitor
0,063  0,048  Beta 3 adrenoreceptor antagonist
0,081  0,066  mTOR complex 2 inhibitor
0,061  0,046  Phosphodiesterase 1C inhibitor
0,027  0,013  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,071  0,058  Alpha 1 adrenoreceptor antagonist
0,086  0,073  Glutamate release inhibitor
0,104  0,092  Retinopathy treatment
0,127  0,116  Mcl-1 antagonist
0,042  0,031  Guanylate cyclase inhibitor
0,077  0,067  Calcium antagonist
0,115  0,106  Cytidine deaminase inhibitor
0,040  0,031  Hypogonadism treatment
0,074  0,065  MAP kinase kinase 7 inhibitor
0,060  0,052  Phosphodiesterase III inhibitor
0,136  0,128  3C-like protease (Human coronavirus) inhibitor
0,067  0,059  Glutamate decarboxylase inhibitor
0,182  0,175  Gastrin inhibitor
0,095  0,089  5 Hydroxytryptamine 2B antagonist
0,077  0,071  Ca(v)3.1 blocker
0,081  0,076  Tocolytic
0,036  0,031  Glutamate (mGluR8) agonist
0,029  0,026  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,104  0,102  Antiprotozoal (Amoeba)
0,030  0,029  Glutamate (mGluR3) agonist
0,029  0,028  Melatonin agonist
0,086  0,084  Chronic obstructive bronchitis treatment
0,067  0,067  GABA aminotransferase inhibitor
0,019  0,018  Estrone sulfatase inhibitor
0,014  0,013  NMDA receptor phencyclidine site antagonist
0,008  0,008  Progesterone receptor A antagonist

